 Solution

ToxB strongly reduces sedimentable wild-type actin, whereas act1-117 shows little additional reduction from its already low baseline. Wild-type actin is mainly in the pellet without drug and mainly in the supernatant with drug. Using the approximate bar heights, the pelleted fraction changes from $740/(740+120)\approx 0.86$ to $280/(280+820)\approx 0.25$. Thus the drug suppresses polymer accumulation but does not eliminate the measured pellet entirely.

For act1-117, the pellet is only about one-third of the recovered signal even without drug, and remains near that fraction with drug: approximately $340/(340+570)\approx 0.37$ and $360/(360+660)\approx 0.35$. The mutant is therefore relatively resistant to the drug's further effect under this assay, but it is not a wild-type-quality polymerizer with an unchanged high polymer mass. These are approximate within-pair fractions; unequal total recoveries and loading limit precise quantitative comparison. sedimentation also requires confirmation that pellet material is filamentous rather than aggregated.